2021
DOI: 10.1155/2021/6001885
|View full text |Cite
|
Sign up to set email alerts
|

Khat Chewing and Lipid Profile in Human and Experimental Animals

Abstract: Background. Catha edulis, also known as khat or qat, is a plant that grows in East Africa and southern Arabia. Several millions of people chew the leaves and twigs of khat plant for their central stimulating amphetamine-like effects. Khat chewing is becoming more common in Europe and the United States, owing to worldwide migration. Objective. This review examines the khat ingredients, global prevalence, and legal status as well as its effects on lipid profile. Methodology. A literature search was performed usi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 54 publications
0
3
0
Order By: Relevance
“…There are no age-specific or gender-specific restrictions on khat consumption. 22 In many Western countries, chewing khat is illegal. Chewing khat has spread significantly to many countries in Asia, Europe, America, and Australia as a result of many waves of migration.…”
Section: Worldwide Spreadmentioning
confidence: 99%
“…There are no age-specific or gender-specific restrictions on khat consumption. 22 In many Western countries, chewing khat is illegal. Chewing khat has spread significantly to many countries in Asia, Europe, America, and Australia as a result of many waves of migration.…”
Section: Worldwide Spreadmentioning
confidence: 99%
“…Dyslipidemia is a term referring to the disorders of lipoprotein metabolism and is clinically characterized by elevated plasma levels of total cholesterol, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, and triglycerides. Available data exploring khat effects on lipid profile are scarce, and conflicting [18].…”
Section: Dyslipidemiamentioning
confidence: 99%
“…Dyslipidemia refers to an elevated amount of serum TC, LDL‐C, and TG and a lower HDL‐C because of problems with lipoprotein metabolism. Dyslipidemia increases CVD and atherosclerosis‐related risk (Al‐Duais & Al‐Awthan, 2021 ). Cholesterol‐lowering medications are used to treat hyperlipidemia, but these medications' detrimental consequences include muscle weakness and liver damage and incur high healthcare costs (Chai et al., 2012 ).…”
Section: Introductionmentioning
confidence: 99%